 | Related Articles |
The use, misuse and abuse of dabigatran.
Med J Aust. 2013 Apr 15;198(7):356-7
Authors: Attia JR, Pearce R
Abstract
The tale of dabigatran sounds some cautionary notes about proper critical appraisal of new randomised controlled trials,care in deciding on the generalisability of results, judicious screening of patients and lessons about the politics around increasingly lucrative drugs. The old lesson of caveat utilitor still holds: let the user beware!
PMID: 23581945 [PubMed - indexed for MEDLINE]